AI in Omics Studies Market Forecast to Reach Over Five Billion Dollars by 2031 Driven by Innovations in Drug Development and Disease Diagnostics

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Al in Omics Studies Market- (By Offering (Software, Services), By Technology Platform (Sequencing, Epigenomics, Proteomics, Metabolomics, Others), By Application (Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Others), By End User (Academic and Research Institutes, Biopharmaceutical Company, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Al in Omics Studies Market is valued at US$ 633.46 Mn in 2023, and it is expected to reach US$ 5,445.6 Mn by 2031, with a CAGR of 31.2% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2363

Artificial intelligence (AI) has become an instrumental technology in addressing the complexities associated with the processing, analysis, and interpretation of omics data, as well as in the integration of multi-omics and clinical information. Recent advancements in AI have significantly impacted various scientific fields, including drug discovery, disease diagnostics, protein structure prediction, and genetic variant interpretation. The AI in omics research market is witnessing consistent growth and is expected to expand substantially over the forecast period. A primary factor driving AI adoption in omics research is its capacity to efficiently handle large and complex datasets, enabling the identification of patterns, prediction of biomarkers, and generation of novel biological insights. The industry's expansion is further supported by increased investment in AI technologies and favorable regulatory frameworks. Collectively, these developments are shaping the future of precision medicine and accelerating the integration of AI solutions within omics research. As a result, AI is poised to transform both omics research and the broader healthcare industry, fueling the global growth of the AI in omics market.

List of Prominent Players in the Al in Omics Studies Market
• Thermo Fisher Scientific.
• Agilent Technologies
• Illumina
• BGI Genomics
• Dassault Systemes
• Qiagen
• Waters Corporation
• GE Healthcare
• Amazon Web Services, Inc
• Bruker
• Danaher
• Other Prominent Players

Market Dynamics:
Drivers-
A primary driver of the AI in omics research market is its significant potential to revolutionize genomics and healthcare. The increasing adoption of AI within this field can be attributed to several critical factors. Firstly, the continual growth in both the volume and complexity of omics data has created a pressing need for advanced analytical tools capable of efficiently processing and deriving actionable insights. AI technologies are particularly well-suited to meet these demands through their superior data analysis capabilities. Secondly, the rising focus on personalized medicine and targeted therapeutic development requires AI-driven methods for accurate biomarker identification and innovative drug discovery. Lastly, strategic collaborations among academic institutions, industry leaders, and healthcare organizations are driving innovation and facilitating the accelerated integration of AI solutions in omics research.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Challenges:
The AI in omics studies sector faces several key challenges, foremost among them being concerns related to data privacy and security, which may impede market expansion. Additionally, the shortage of skilled AI professionals presents a significant barrier, particularly given the stringent regulatory environment governing the field. The rising demand for AI applications in genomics is constrained by the limited availability of experts with the necessary proficiency in AI technologies. Furthermore, the inherent complexity of AI systems in genomics requires specialized expertise, which remains underdeveloped, thereby limiting the smooth integration of AI into genomic workflows and hindering advancement. Regulatory frameworks addressing data security, privacy, and ethical considerations add further complexity to the adoption of AI within genomics.

Regional Trends:
As of 2023, North America led the global AI in omics market, commanding a substantial portion of market revenue. This dominance is attributed to the presence of numerous leading industry players, including Google Health, Danone, Abbott, Nestlé, IBM, and Targeted Medical Pharma, Inc. The region also hosts some of the world's most prominent and well-funded research institutions and biotechnology companies, which are heavily investing in AI-driven genomics solutions, thereby driving regional market growth. Meanwhile, the Asia-Pacific market is projected to experience significant growth, supported by its large population base, increasing emphasis on precision medicine and genomics technologies, and escalating healthcare expenditures. These factors collectively are fueling demand for AI-based genomics solutions in the region.

Recent Developments:
• In November 2023, biotechnology companies OWKIN and 10x Genomics, Inc., jointly announced that they have reached an agreement to incorporate 10x Genomics' single-cell and spatial omics technologies to their work in tumour investigation for potential therapeutic targets.
• In September 2023, Janssen Global Services, LLC, a pharmaceutical firm, and Intelligent OMICS Ltd., a biotechnology company, agreed to a partnership in AI-driven research. The goal of the partnership with Janssen Global Services, LLC is to identify new biological targets that can be used to treat haematological malignancies.
• in June 2022, the Ultima Genomics firm and Nvidia announced that they are partnering to separate AI at various stages of the DNA sequencing and analysis process. Accelerating variant calling and deep learning in photometry and base calling are two aspects of the relationship.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2363

Segmentation of Al in Omics Studies Market -
By Offering:
• Software
• Services
By Technology Platform:
• Sequencing
• Epigenomics
• Proteomics
• Metabolomics
• Others (Transcriptomics, among others)
By Application:
• Oncology
• Infectious Diseases
• Neurology
• Cardiovascular Diseases
• Immunology
• Others (Pharmacogenomics, among others)
By End User:
• Academic and Research Institutes
• Biopharmaceutical Company
• Others (Contract Research Organizations, among others)
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/ai-in-omics-studies-market/2363

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.